Breast cancer is divided into various subtypes on the basis of the expression status of human epidermal growth factor receptor 2 (HER2) and of estrogen (ER) and progesterone (PR) receptors by immunohistochemical staining or gene expression profiles [5, 6]. Here, ERBB2 is linked to breast carcinoma.